Literature DB >> 12739733

Acromegaly: disease or syndrome? Not only a semantic question.

Giovanni Faglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12739733     DOI： 10.1007/BF03345134

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  13 in total

Review 1.  111In-octreotide scintigraphy in oncology.

Authors:  E P Krenning; D J Kwekkeboom; J C Reubi; P M Van Hagen; C H van Eijck; H Y Oei; S W Lamberts
Journal:  Metabolism       Date:  1992-09       Impact factor: 8.694

2.  Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone.

Authors:  S L Asa; K Kovacs; L Stefaneanu; E Horvath; N Billestrup; C Gonzalez-Manchon; W Vale
Journal:  Proc Soc Exp Biol Med       Date:  1990-03

Review 3.  Mutations in G proteins and G protein-coupled receptors in endocrine disease.

Authors:  A M Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

4.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

5.  Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor.

Authors:  S Melmed; C Ezrin; K Kovacs; R S Goodman; L A Frohman
Journal:  N Engl J Med       Date:  1985-01-03       Impact factor: 91.245

6.  Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.

Authors:  C O Evans; M R Brown; J S Parks; N M Oyesiku
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

7.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

8.  Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella.

Authors:  G Osella; F Orlandi; P Caraci; M Ventura; D Deandreis; M Papotti; M Bongiovanni; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

9.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Authors:  M O Thorner; R L Perryman; M J Cronin; A D Rogol; M Draznin; A Johanson; W Vale; E Horvath; K Kovacs
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

Review 10.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871
View more
  1 in total

1.  Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma.

Authors:  E Verrua; C L Ronchi; E Ferrante; D I Ferrari; S Bergamaschi; S Ferrero; M C Zatelli; V Branca; A Spada; P Beck-Peccoz; A G Lania
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.